1 Unpopular Stock That Deserves Some Love and 2 We Avoid

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. Keeping that in mind, here is one stock poised to prove Wall Street wrong and two where the outlook is warranted.

Two Stocks to Sell:

Paramount (PSKY)

Consensus Price Target: $9.81 (-3.7% implied return)

Owner of Spongebob Squarepants and formerly known as ViacomCBS, Paramount Global (NASDAQ:PSKY) is a major media conglomerate offering television, film production, and digital content across various global platforms.

Why Do We Pass on PSKY?

1. Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 1.8% over the last five years was below our standards for the consumer discretionary sector
2. Capital intensity will likely increase as its free cash flow margin is anticipated to drop by 1.8 percentage points over the next year
3. Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions

Paramount’s stock price of $10.19 implies a valuation ratio of 12.5x forward P/E. To fully understand why you should be careful with PSKY, check out our full research report (it’s free).

Inspire Medical Systems (INSP)

Consensus Price Target: $60.40 (-3.3% implied return)

Offering an alternative for the millions who struggle with traditional CPAP machines, Inspire Medical Systems (NYSE:INSP) develops and sells an implantable neurostimulation device that treats obstructive sleep apnea by stimulating nerves to keep airways open during sleep.

Why Does INSP Fall Short?

1. Revenue base of $898.7 million puts it at a disadvantage compared to larger competitors exhibiting economies of scale
2. Projected sales decline of 3.5% for the next 12 months points to a tough demand environment ahead

At $62.45 per share, Inspire Medical Systems trades at 45.2x forward P/E. Check out our free in-depth research report to learn more about why INSP doesn’t pass our bar.

One Stock to Watch:

Molina Healthcare (MOH)

Consensus Price Target: $209.12 (2.8% implied return)

Founded in 1980 as a provider for underserved communities in Southern California, Molina Healthcare (NYSE:MOH) provides managed healthcare services primarily to low-income individuals through Medicaid, Medicare, and Marketplace insurance programs across 21 states.

Why Do We Like MOH?

1. Annual revenue growth of 13.7% over the last five years beat the sector average and underscores the unique value of its offerings
2. Sizeable revenue base of $44.52 billion gives it economies of scale and favorable reimbursement terms with healthcare providers

Molina Healthcare is trading at $203.44 per share, or 28.1x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.